Sep 5
|
Should You Still Buy the Dow Jones' Best-Performing August Stocks?
|
Sep 5
|
Analysis-FTC settlement could shelter Amgen from US price cuts, taxes
|
Sep 4
|
FTC Allows Amgen (AMGN) to Proceed With $28B Horizon Buyout
|
Sep 4
|
Amgen (AMGN) is a Top-Ranked Momentum Stock: Should You Buy?
|
Sep 1
|
Dow Jones Today: Index Moves Up on Jobs Report
|
Sep 1
|
Why Amgen's $28 Billion Merger News Also Bodes Well For Pfizer, Biogen
|
Sep 1
|
Amgen’s $27.8 Billion Deal for Horizon Therapeutics Clears Key Hurdle
|
Sep 1
|
Amgen, FTC Settle Over $27.8 Billion Horizon Deal. Stocks Rise.
|
Sep 1
|
Amgen gets green light from FTC for $27.8B Horizon Therapeutics deal
|
Sep 1
|
Amgen resolves US regulator’s challenge to $28bn Horizon deal
|
Sep 1
|
Horizon Therapeutics Stock Rises After Settlement Clears Way for Amgen Deal
|
Sep 1
|
Amgen’s $27.8 Billion Horizon Takeover Allowed in FTC Accord
|
Sep 1
|
AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION
|
Sep 1
|
Amgen gets US FTC's go-ahead for $27.8 billion Horizon deal
|
Sep 1
|
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
|
Aug 31
|
AMGEN TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCE AND THE CITI GLOBAL HEALTHCARE CONFERENCE
|
Aug 31
|
Big Pharma's biggest ally gets trolled on X for attacking Medicare drug pricing list
|
Aug 31
|
Is This the Green Light Biotech Stocks Have Been Waiting For?
|
Aug 30
|
Medicare's drug pricing list didn't impact company stocks — here's why
|
Aug 30
|
Medicare price negotiation list: What it means for pharma companies
|